Home › Funds › Birchview Capital, LP › CAMP
Birchview Capital, LP position in CAMP
CAMP4 THERAPEUTICS CORP · Health Care
Birchview Capital, LP reported holding 120,000 shares of CAMP (CAMP4 THERAPEUTICS CORP) in its Q3 2026 13F filing — a position valued at US$485K, representing 0.29% of its reported portfolio and ranking #50 among its reported holdings. Birchview Capital, LP has disclosed CAMP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Birchview Capital, LP's CAMP position evolved
Birchview Capital, LP first disclosed a stake in CAMP in Q2 2026 at 120,000 shares (US$524K). Across 2 filings, Birchview Capital, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 120,000 shares valued at US$485K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 120.00K | $524.40K | New |
| Q3 2026 | 120.00K | $484.80K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAMP and 13F data
CAMP (CAMP4 THERAPEUTICS CORP) is a Health Care company. 37 other funds we track also report a position in CAMP — the largest reported positions include 5AM Venture Management, LLC (US$25.6M), Vivo Capital, LLC (US$22.6M), Stonepine Capital Management, LLC (US$11.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAMP
- 5AM Venture Management, LLC 5.87M sh · $25.65M · Q2 2026
- Vivo Capital, LLC 5.58M sh · $22.56M · Q3 2026
- Stonepine Capital Management, LLC 2.79M sh · $11.26M · Q3 2026
- a16z Capital Management, L.L.C. 2.13M sh · $9.29M · Q2 2026
- Trails Edge Capital Partners, LP 1.93M sh · $8.45M · Q2 2026
- Enavate Sciences GP, LLC 1.43M sh · $6.23M · Q2 2026
- HARBOURVEST PARTNERS LLC 1.27M sh · $5.56M · Q2 2026
More on Birchview Capital, LP
FAQ
How long has Birchview Capital, LP held CAMP?
Birchview Capital, LP has disclosed CAMP holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Birchview Capital, LP's current position in CAMP?
As of Q3 2026, Birchview Capital, LP holds 120.00K shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $484.80K, representing 0.29% of its reported portfolio and ranking #50.
Has Birchview Capital, LP been buying or selling CAMP?
In the latest 13F filing (Q3 2026), Birchview Capital, LP held unchanged its position in CAMP.
Which other funds hold CAMP?
Other major institutional holders of CAMP include 5AM Venture Management, LLC, Vivo Capital, LLC, Stonepine Capital Management, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.